Table 1.
Event forms | Screening | 3 weeks | 6 weeks* | 3 months | 6 months | 12 months |
(2–4 weeks) | (5–7 weeks) | (11–15 weeks) | (6–7 months) | (12–14 months) | ||
Screening | X | |||||
Informed consent | X | |||||
Patient characteristics | X | |||||
Injury characteristics | X | |||||
Radiology | X† | X† | X† | X† | X† | |
Digital photo | X† | X† | X† | X† | X† | |
Treatment characteristics | X | X | X | X | X | |
Outcome details | X | X | X | X | X | |
Adverse events | X | X | X | X | X | |
Clinical FU | X | X | X | X | X | |
Healthcare consumption | X | X | X | X | X | |
EQ-5D | X‡ | X | X | X | ||
POSAS | X | X | X | |||
Early withdrawal | § | § | § | § | § |
*Optional visit; will only take place if wounds are not closed at 3 weeks.
†Only if treating surgeon requests these images.
‡Asking for EQ-5D preburn.
§Only at time of withdrawal.
EQ-5D, EuroQoL-5D; FU, follow-up; POSAS, Patient and Observer Scar Assessment Scale.